Guru Ownership Trend
Guru Analysis for Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. (NMRA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.28 M.
Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.69 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Steven Cohen reduced exposure by 83.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Neumora Therapeutics, Inc. (NMRA)
Major holders include Renaissance Technologies (RenTech) ($2.71 M), Paul Tudor Jones ($1.5 M), Steven Cohen ($1.17 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.85 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.69 M, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited NMRA. The total reported sell value was $6.2 M.
Yes, 1 managers opened new positions in NMRA, and 0 increased their existing holdings. The total reported buy value was $1.5 M.